Vigilancia Tecnológica

The present invention provides an aqueous liquid formulation which contains: arbekacin and/or a salt thereof; and at least one water-soluble polymer that is selected from the group consisting of a hydroxypropylmethyl cellulose, a hydroxyethyl cellulose, a methyl cellulose and a polyvinylpyrrolidone.